amantadine

medication to treat dyskinesia associated with parkinsonism

Details

Instance of: type of chemical entity
Subclass of: chemical compound
Has parts: nitrogen, carbon
active ingredient in: Gocovri
canonical SMILES: C1C2CC3CC1CC(C2)(C3)N
catalog: CAS COVID-19 Anti-Viral Candidate Compounds
chemical formula: C₁₀H₁₇N
defined daily dose: 0.2
found in taxon: Microcystis ichthyoblabe
has use: medication
LiverTox likelihood score: LiverTox toxicity likelihood category E
mass: 151.1361
medical condition treated: Parkinson's disease, influenza, Parkinson's disease, malignant syndrome in Parkinson's disease
physically interacts with: Glutamate ionotropic receptor NMDA type subunit 2A, Glutamate ionotropic receptor NMDA type subunit 2B, Glutamate ionotropic receptor NMDA type subunit 2C, Glutamate ionotropic receptor NMDA type subunit 2D
pregnancy category: Australian pregnancy category B3, US pregnancy category C
significant drug interaction: pimozide, fluphenazine, olanzapine, loxapine, chlorpromazine
subject has role: antiparkinson, non-opioid analgesic, antiviral agent, dopaminergic, bactericide, antiviral drug, nootropic

Nothing in the MetaHistoryBook collection references this item yet.